XNAS: IKT
Inhibikase Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosin...
Read More
1.94
0.03
(1.57%)
451.9K
XNAS Volume
XNAS 04 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Inhibikase Therapeutics Inc is on 14 May 2026 for the purpose of Inhibikase Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inhibikase Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..